CoChat
Sign Up
Cited by 124Liver Diseases and ImmunityLiver physiology and pathologyDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

The pathobiology of biliary epithelia

Roberts, SK, Ludwig, J, Larusso, NF·1997·Gastroenterology
DOI 10.1016/s0016-5085(97)70244-0
Open this paper in CoChat — free account

Abstract

Our understanding of the pathobiology of biliary epithelia is rapidly growing because of a surge of investigative activity. This became possible after suitable experimental models and techniques were developed with which to study cholangiocyte biology. Although the molecular mechanisms of bile formation by cholangiocytes and the role of these cells as a major cellular target in a variety of severe hepatobiliary diseases are currently being investigated, many questions remain unanswered, particularly regarding cholangiocellular functions, both in normal and abnormal conditions. As current experimental models become more refined, scientists with interests as diverse as cell biology and physiology, morphology, pharmacology, immunology, genetics, and oncology can be expected to further clarify the pathobiology of biliary epithelia.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0016-5085(97)70244-0

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 124

Related

See all

Metadata

Authors
Roberts, S., Ludwig, J., & Larusso, N.
Affiliations
Mayo Clinic (US)
ORCID
Ludwig, J
Venue
Gastroenterology
Publisher
Elsevier BV
Published
1997-01
Volume
112
Issue
1
Pages
269-279
ISSN
0016-5085 (ISSN-L)
DOI
10.1016/s0016-5085(97)70244-0
OpenAlex
W2062038681
Cited by
124
References
28
Citations by year
2025: 2 · 2023: 3 · 2022: 1 · 2020: 4 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 5
FWCI
6.28
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
cholangiocytes, bile formation, hepatobiliary diseases, experimental model, biliary tract physiology
MeSH terms
Autoimmune Diseases, Bile, Bile Duct Diseases, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cell Division, Cells, Cultured, Cholangitis, Humans, Liver Cirrhosis, Biliary, Cholangiocarcinoma

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review